Tumor Vaccines Expressing Flt3 Ligand Synergize With CTLA-4 Blockade to Reject Preimplanted Tumors

Cancer Research - United States
doi 10.1158/0008-5472.can-08-3289
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

CTLA-4 Blockade Synergizes With Cryoablation to Mediate Tumor Rejection

OncoImmunology
OncologyAllergyImmunology
2012English

mRNA-based Vaccines Synergize With Radiation Therapy to Eradicate Established Tumors

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2014English

Dual Blockade of PD-1 and CTLA-4 Combined With Tumor Vaccine Effectively Restores T-Cell Rejection Function in Tumors—Response

Cancer Research
Cancer ResearchOncology
2014English

CTLA-4 Blockade Boosts the Expansion of Tumor-Reactive CD8+ Tumor-Infiltrating Lymphocytes in Ovarian Cancer

Scientific Reports
Multidisciplinary
2020English

Radiotherapy Enhances Responses of Lung Cancer to CTLA-4 Blockade

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2019English

Correction: Durable Therapeutic Efficacy Utilizing Combinatorial Blockade Against IDO, CTLA-4, and PD-L1 in Mice With Brain Tumors

Clinical Cancer Research
Cancer ResearchOncology
2015English

CTLA-4 Blockade Synergizes Therapeutically With PARP Inhibition in BRCA1-Deficient Ovarian Cancer

Cancer immunology research
Cancer ResearchImmunology
2015English

Robust Antitumor Responses Result From Local Chemotherapy and CTLA-4 Blockade

Cancer immunology research
Cancer ResearchImmunology
2018English

Heterologous Vaccination and Checkpoint Blockade Synergize to Induce Antileukemia Immunity

Journal of Immunology
AllergyImmunology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy